Troels Yndigegn

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Left Ventricular

Acute Myocardial Infarction

Angiotensin Converting Enzyme

Clinical Practice

Top Venues

Journal of the American Heart Association

European heart journal. Cardiovascular pharmacotherapy

Heart (British Cardiac Society)

European journal of preventive cardiology

This page only lists publications with an associated author ORCID identifier.

Publications

Katarina Mars, Sophia Monica Humphries, Philip Leissner, Martin Jonsson, Patric Karlström, Jörg Lauermann, Joakim Alfredsson, Thomas Kellerth, Annica Ravn Fischer, David Erlinge, Bertil Lindahl, Troels Yndigegn, Tomas Jernberg, Claes Held, Erik M G Olsson, Robin Hofmann
Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMI. European heart journal. Cardiovascular pharmacotherapy (2024)
Ali Yari, Peter Ueda, Pia Lundman, Joakim Alfredsson, Annica Ravn Fischer, Stefan Söderberg, Troels Yndigegn, Emil Hagström, Tomas Jernberg
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 (SCORE2) according to guidelines on apparently healthy middle-aged individuals. European journal of preventive cardiology (2024)
Kerstin Welén Schef, Per Tornvall, Joakim Alfredsson, Emil Hagström, Annica Ravn-Fischer, Stefan Söderberg, Troels Yndigegn, Tomas Jernberg
Prevalence of angina pectoris and association with coronary atherosclerosis in a general population. Heart (British Cardiac Society) (2023)
Karolina Berntorp, Rebecca Rylance, Troels Yndigegn, Sasha Koul, Ole Fröbert, Evald H Christiansen, David Erlinge, Matthias Götberg
Clinical Outcome of Revascularization Deferral With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A 5-Year Follow-Up Substudy From the iFR-SWEDEHEART Trial. Journal of the American Heart Association 12 (3) (2023)
Karolina Berntorp, Rebecca Rylance, Troels Yndigegn, Sasha Koul, Ole Fröbert, Evald H Christiansen, David Erlinge, Matthias Götberg
Clinical Outcome of Revascularization Deferral With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A 5-Year Follow-Up Substudy From the iFR-SWEDEHEART Trial. Journal of the American Heart Association (2023)
Karolina Berntorp, Rebecca Rylance, Troels Yndigegn, Sasha Koul, Ole Fröbert, Evald H Christiansen, David Erlinge, Matthias Götberg
Clinical Outcome of Revascularization Deferral With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A 5-Year Follow-Up Substudy From the iFR-SWEDEHEART Trial. Journal of the American Heart Association 12 (3) (2023)
Troels Yndigegn, Bertil Lindahl, Joakim Alfredsson, Jocelyne Benatar, Lisa Brandin, David Erlinge, Urban Haaga, Claes Held, Pelle Johansson, Patric Karlström, Thomas Kellerth, Toomas Marandi, Katarina Mars, Annica Ravn Fischer, Johan Sundström, Ollie Östlund, Robin Hofmann, Tomas Jernberg
Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI). European heart journal. Cardiovascular pharmacotherapy 9 (2) (2023)
Divan Ishak, Suleman Aktaa, Lars Lindhagen, Joakim Alfredsson, Tatendashe Bernadette Dondo, Claes Held, Tomas Jernberg, Troels Yndigegn, Chris P Gale, Gorav Batra
Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes. Heart (British Cardiac Society) (2023)
Karolina Berntorp, Rebecca Rylance, Troels Yndigegn, Sasha Koul, Ole Fröbert, Evald H Christiansen, David Erlinge, Matthias Götberg
Clinical Outcome of Revascularization Deferral With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A 5-Year Follow-Up Substudy From the iFR-SWEDEHEART Trial. Journal of the American Heart Association 12 (3) (2023)
Karolina Berntorp, Rebecca Rylance, Troels Yndigegn, Sasha Koul, Ole Fröbert, Evald H Christiansen, David Erlinge, Matthias Götberg
Clinical Outcome of Revascularization Deferral With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A 5-Year Follow-Up Substudy From the iFR-SWEDEHEART Trial. Journal of the American Heart Association 12 (3) (2023)
Moman Aladdin Mohammad, Jonas Persson, Sergio Buccheri, Jacob Odenstedt, Giovanna Sarno, Oskar Angerås, Sebastian Völz, Tim Tödt, Matthias Götberg, Nazim Isma, Troels Yndigegn, Patrik Tydén, Dimitrios Venetsanos, Mats Birgander, Göran K Olivecrona
Trends in Clinical Practice and Outcomes After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery. Journal of the American Heart Association 11 (7) (2022)
Troels Yndigegn, Tomas Jernberg
Beta-blocker therapy after myocardial infarction guided by left ventricular ejection fraction: is 50 the new 40? European heart journal. Cardiovascular pharmacotherapy 7 (6) (2022)
Niklas Ekerstad, Dariush Javadzadeh, Karen P Alexander, Olle Bergström, Lars Eurenius, Mats Fredrikson, Gudny Gudnadottir, Claes Held, Karin Hellström Ängerud, Radwan Jahjah, Tomas Jernberg, Ewa Mattsson, Kjell Melander, Linda Mellbin, Monica Ohlsson, Annica Ravn Fischer, Lars Svennberg, Troels Yndigegn, Joakim Alfredsson
Clinical Frailty Scale classes are independently associated with 6-month mortality for patients after acute myocardial infarction. European heart journal. Acute cardiovascular care 11 (2) (2022)
Troels Yndigegn, Bertil Lindahl, Joakim Alfredsson, Jocelyne Benatar, Lisa Brandin, David Erlinge, Urban Haaga, Claes Held, Pelle Johansson, Patric Karlström, Thomas Kellerth, Toomas Marandi, Katarina Mars, Annica Ravn Fischer, Johan Sundström, Ollie Östlund, Robin Hofmann, Tomas Jernberg
Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI). European heart journal. Cardiovascular pharmacotherapy (2022)
Axel Wester, Moman Aladdin Mohammad, Göran Olivecrona, Jasminka Holmqvist, Troels Yndigegn, Sasha Koul
Validation of the 4-Item PRECISE-DAPT Score: A SWEDEHEART Study. Journal of the American Heart Association 10 (20) (2021)
Troels Yndigegn, Robin Hofmann, Tomas Jernberg, Chris P Gale
Registry-based randomised clinical trial: efficient evaluation of generic pharmacotherapies in the contemporary era. Heart (British Cardiac Society) 104 (19) (2018)